Company / FCF Margin
Cyclerion Therapeutics, Inc. FCF Margin History
FY2019-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-13673.7%
FY2022
5-year range
-13673.7% / -3223.6%
FY2019-FY2022
Trend
-324.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin changed -324% YoY in FY2022, a notable deviation from the 3-year average annual change of -122%.
Based on SEC 10-K filings.
-13673.7% in FY2022 with a 3-year CAGR of -11434.1%.
Declined from -2420.8% to -13673.7% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -11434.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Cyclerion Therapeutics, Inc.'s fcf margin has declined for 3 consecutive years.
- In FY2022, fcf margin decreased 324.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -13673.7% | -324.2% |
| FY2021 | -3223.6% | -33.2% |
| FY2020 | -2420.8% | -8.1% |
| FY2019 | -2239.7% | - |
As of FY2022 · SEC 10-K Annual Filings · Updated Jun 24, 2026